This story is from April 02, 2016
Indian-American professor selected for Fulbright specialist roster
HOUSTON: An Indian-American professor and pharmaceutical department chair at a prestigious American university has been selected for the Fulbright Specialist Roster for his outstanding achievements in the field of pharmacy.
Rajendra R Aparasu is the first pharmacy faculty member at the University of Houston selected to be the candidate roster of the Fulbright Specialist Programme, which helps US faculty share their academic expertise and develop linkages with non- US institutions on curriculum, assessment, faculty development and research training.
The Fulbright programme, which is funded by the Department of State's Bureau of Educational and Cultural Affairs, serves to promote international engagement of academic scholarship and build linkages between US and overseas institutions.
"There are very few Fulbright specialists in pharmacy; I am really honoured to be selected for Fulbright Specialist Roster," said Aparasu, whose five-year term ends in 2021.
"This is a great opportunity to offer my expertise in developing professional and graduate pharmacy programmes that involve pharmaceutical health outcomes and policy," he said.
"I am looking forward to the opportunity to visit overseas pharmacy institutions to assist faculty and administrators with respect to academic and research programs in pharmaceutical outcomes research."
Aparasu obtained his Bachelor of Pharmacy (BPharm) from Kakatiya University, and Master of Pharmacy (MPharm), from Jadavpur University, India.
Aparasu obtained his Ph.D in Pharmacy Administration, University of Louisiana, Monroe, LA and joined University of Texas in 2006 after serving on the faculty at the South Dakota State University for more than a decade.
His primary areas of expertise include geriatrics, pharmacoepidemiology, psychopharmacology and evidence-based medicine.
His current research project, supported by a grant from the Agency for Healthcare Research and Quality (AHRQ), is evaluating safety profiles of anticholinergic medications in the elderly nursing home residents.
He has authored and co-authored nearly 100 peer-reviewed journal articles and seven book chapters, as well as served as editor or co-editor of two books (Principles of Research Design and Drug Literature and Research Methods for Pharmaceutical Practice and Policy).
Aparasu was recognised by his peers with the Fellow of the American Pharmacists Association (FAPhA) for his exemplary professional achievements and outstanding service and contribution to the pharmacy profession.
He holds editorial board appointments on six peer-review journals and has been recognised as an "exceptional" reviewer by five peer-review journals.
The Fulbright programme, which is funded by the Department of State's Bureau of Educational and Cultural Affairs, serves to promote international engagement of academic scholarship and build linkages between US and overseas institutions.
"There are very few Fulbright specialists in pharmacy; I am really honoured to be selected for Fulbright Specialist Roster," said Aparasu, whose five-year term ends in 2021.
"This is a great opportunity to offer my expertise in developing professional and graduate pharmacy programmes that involve pharmaceutical health outcomes and policy," he said.
"I am looking forward to the opportunity to visit overseas pharmacy institutions to assist faculty and administrators with respect to academic and research programs in pharmaceutical outcomes research."
Aparasu obtained his Bachelor of Pharmacy (BPharm) from Kakatiya University, and Master of Pharmacy (MPharm), from Jadavpur University, India.
His primary areas of expertise include geriatrics, pharmacoepidemiology, psychopharmacology and evidence-based medicine.
His current research project, supported by a grant from the Agency for Healthcare Research and Quality (AHRQ), is evaluating safety profiles of anticholinergic medications in the elderly nursing home residents.
He has authored and co-authored nearly 100 peer-reviewed journal articles and seven book chapters, as well as served as editor or co-editor of two books (Principles of Research Design and Drug Literature and Research Methods for Pharmaceutical Practice and Policy).
Aparasu was recognised by his peers with the Fellow of the American Pharmacists Association (FAPhA) for his exemplary professional achievements and outstanding service and contribution to the pharmacy profession.
He holds editorial board appointments on six peer-review journals and has been recognised as an "exceptional" reviewer by five peer-review journals.
Top Comment
S
Saranathan Lakshminarasimhan
3141 days ago
Great recognitionRead allPost comment
Popular from Business
- Mahindra renames EV on IndiGo protest, to move court
- Paytm arm to sell Stock Acquisition Rights in Japan's PayPay for Rs 2,364 crore
- Infosys' Narayana Murthy buys luxury flat in Kingfisher Towers for Rs 50 crore
- UPI empowered marginal borrowers, boosted credit access: Study
- 'Doubt on credibility': IndiGo dismisses low ranking in global survey
end of article
Trending Stories
- UPI empowered marginal borrowers, boosted credit access: Study
- 'Doubt on credibility': IndiGo dismisses low ranking in global survey
- Infosys' Narayana Murthy buys luxury flat in Kingfisher Towers for Rs 50 crore
- Mahindra renames EV on IndiGo protest, to move court
- India’s first Hyperloop test track is ready! Railway Minister Ashwini Vaishnaw shares exciting update
- RBI Monetary Policy Meeting Highlights: Shaktikanta Das-led MPC keeps repo rate unchanged, cuts CRR to 4%; GDP FY25 outlook revised down to 6.6%
- Stock market today: BSE Sensex opens flat ahead of RBI policy; Nifty50 above 24,700
Visual Stories
- NEET UG 2024 result awaited: Top 10 NIRF-ranked medical colleges of India
- 7 New Expected Bullet Train Routes in India
- 10 Upcoming High-Speed Expressways That Will Change Highway Travel In India
- 8 Transformational Indian Railways Projects You Shouldn’t Miss
- Why Sensex, Nifty50 Hit New Highs, M-Cap At $5 Trillion: Top Reasons
UP NEXT